Skip to Content

Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors

The NORDIC SUN trial is currently investigating the effectiveness and timing of cytoreductive nephrectomy in patients with newly diagnosed synchronous metastatic renal cell carcinoma (mRCC) being treated with IO-treatment regimens.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top